European Archives - Page 267 of 1389 - European Medical Journal

PPAR Agonists in PBC

Primary biliary cholangitis (PBC) is characterised by the presence of disease-specific autoantibodies and persistently elevated liver…

22 May 2025

A Novel Therapeutic Target Pathway for Multiple Sclerosis

This interactive infographic gives an overview of a novel target pathway in multiple sclerosis (MS), focusing on the critical role of CD40/CD40L.

Paolo Gallipoli

Hema Now: Episode 17: What Drives Change in Leukaemia Cells?

Paolo Gallipoli, Clinical Reader, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London joins the podcast to discuss the biology, onset, and treatment of myeloid leukaemias.

First-Ever Human Bladder Transplant Marks Medical Milestone

Gill described the event as a “historic moment in medicine,” potentially transforming treatment options for patients.

British government buildings

BioNTech commits £1bn to UK in landmark life sciences investment

BioNTech is set to invest up to £1bn in the UK over the next decade, establishing new R&D and AI hubs.

COMy 2025: CAR-T Cell Therapy Access Gaps in Myeloma

At COMy 2025, researchers highlighted barriers to EMA-approved CAR-T cell therapy access due to age, comorbidities, and inequality.

EuroPCR 2025: FFR-Guided PCI Lowers Complications After TAVI

Physiology-guided PCI halves major complications after TAVI compared to angiography alone, new FAITAVI trial data show.

COMy 2025: Dual Testing After Transplant Predicts Better Myeloma Outcomes

A study presented at COMy 2025 found that dual MRD testing with bone marrow flow cytometry and PET/CT imaging better predicts progression-free survival in patients with multiple myeloma after autologous stem cell transplantation.

Transforming Rheumatology

  In this series, Isabelle Amigues, rheumatologist and founder of UnabridgedMD, a direct rheumatology practice in Denver, Colorado, USA, discusses the importance of hope in patient care and the inspiration behind starting her own practice.

COMy 2025: Diagnosis Delays in Amyloid Light-Chain Amyloidosis

Despite therapeutic advances, delayed diagnosis of amyloid light-chain amyloidosis remains a major clinical challenge, according to data shared at the 2025 COMy Congress.